Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells
| dc.authorid | gumus, nurcan/0000-0001-9989-4590 | |
| dc.authorid | Tezcanli KAYMAZ, Burcin/0000-0003-1832-1454 | |
| dc.authorid | Celik, Besne/0000-0001-5417-8005 | |
| dc.authorid | Avci, Cigir Biray/0000-0001-8251-4520 | |
| dc.contributor.author | Tezcanli Kaymaz, Burcin | |
| dc.contributor.author | Gumus, Nurcan | |
| dc.contributor.author | Celik, Besne | |
| dc.contributor.author | Alcitepe, Ilayda | |
| dc.contributor.author | Biray Avci, Cigir | |
| dc.contributor.author | Aktan, Cagdas | |
| dc.date.accessioned | 2025-03-09T10:48:53Z | |
| dc.date.available | 2025-03-09T10:48:53Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Beykent Üniversitesi | |
| dc.description.abstract | Chronic myeloid leukemia (CML) is a clonal myeloproliferative hematological disease characterized by the chimeric breakpoint-cluster region/Abelson kinase1 (BCR | |
| dc.identifier.doi | 10.1089/jir.2023.0170 | |
| dc.identifier.endpage | 189 | |
| dc.identifier.issn | 1079-9907 | |
| dc.identifier.issn | 1557-7465 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 38579140 | |
| dc.identifier.scopus | 2-s2.0-85190333642 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 178 | |
| dc.identifier.uri | https://doi.org/10.1089/jir.2023.0170 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12662/4680 | |
| dc.identifier.volume | 44 | |
| dc.identifier.wos | WOS:001197190100002 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Mary Ann Liebert, Inc | |
| dc.relation.ispartof | Journal of Interferon and Cytokine Research | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250310 | |
| dc.subject | ponatinib | |
| dc.subject | combination therapy | |
| dc.subject | cytokines | |
| dc.subject | STAT5 inhibitor pimozide | |
| dc.subject | drug resistance | |
| dc.title | Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells | |
| dc.type | Article |












